High-growth stocks that are financially stable are attractive for many reasons. They provide a strong upside to your portfolio, with less likelihood of downside risks compared to less financially robust companies. If your holdings could benefit from diversification towards growth stocks, whether it be in reputable tech stocks or green small-caps, take a look at my list of stocks with a bright future ahead.
SITO Mobile, Ltd. (NASDAQ:SITO)
SITO Mobile, Ltd. operates a mobile location-based advertising platform in the United States and Canada. Established in 2000, and run by CEO Thomas Pallack, the company now has 70 employees and with the company’s market cap sitting at USD $118.68M, it falls under the small-cap category.
Driven by exceptional sales, which is expected to more than double over the next few years, SITO is expected to deliver an excellent earnings growth of 60.29%. It appears that SITO’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. SITO’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about SITO? Have a browse through its key fundamentals here.
Tellurian Inc. (NASDAQ:TELL)
Tellurian Investments Inc. offers mid-scale natural gas liquefaction and export projects. Started in 2015, and run by CEO Meg Gentle, the company size now stands at 39 people and with the company’s market cap sitting at USD $1.92B, it falls under the small-cap group.
TELL’s projected future profit growth is an exceptional 66.61%, with an underlying 50.98% growth from its cash flow from operations expected over the upcoming years. Profit growth, coupled with operating cash flow expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. TELL’s bullish prospects make it an interesting stock to invest more time to understand how it can add value to your portfolio. Could this stock be your next pick? Have a browse through its key fundamentals here.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain. Established in 2002, and headed by CEO Michael Heffernan, the company provides employment to 234 people and with the company’s market capitalisation at USD $951.14M, we can put it in the small-cap stocks category.
COLL is expected to deliver an extremely high earnings growth over the next couple of years of 59.11%, bolstered by a significant revenue which is expected to more than double. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. COLL ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Could this stock be your next pick? Take a look at its other fundamentals here.
For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.